MedPath
HSA Approval

INON GRANULES

SIN03440P

INON GRANULES

INON GRANULES

June 8, 1989

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSATO PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderSATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

GRANULE

ORAL

Medical Information

A02AH

配有碳酸氢钠的治酸药

Manufacturer Information

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL CO LTD

Active Ingredients

ALUMINIUM HYDROXIDE (DRIED GEL)

525 mg/1.8 g

Aluminum hydroxide

SODIUM BICARBONATE

525 mg/1.8 g

Sodium bicarbonate

MAGNESIUM CARBONATE

350 mg/1.8 g

Magnesium carbonate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

INON GRANULES - HSA Approval | MedPath